| 1 |
Sane DC, Anton L, Brosnihan KB. Angiogenic growth factors and hypertension. Angiogenesis 2004;7:193-201.
DOI
ScienceOn
|
| 2 |
Redon J. Antihypertensive treatment: should it be titrated to blood pressure reduction or to target organ damage regression? Curr Opin Nephrol Hypertens 2005;14:448-52.
DOI
ScienceOn
|
| 3 |
Lee JS, Song SH, Kim JM, et al. Angiopoietin-1 prevents hypertension and target organ damage through its interaction with endothelial Tie2 receptor. Cardiovasc Res 2008;78:572-80.
DOI
ScienceOn
|
| 4 |
Suh W, Lee JS, Kim KL, Song SH, Koh GY, Kim DK. Angiopoietin-1 gene therapy attenuates hypertension and target organ damage in nitric oxide synthase-inhibited spontaneously hypertensive rats. Korean Circ J 2011;41:590-5.
DOI
|
| 5 |
Koller A. Signaling pathways of mechanotransduction in arteriolar endothelium and smooth muscle cells in hypertension. Microcirculation 2002;9:277-94.
DOI
|
| 6 |
Rizzoni D, Rodella L, Porteri E, et al. Time course of apoptosis in small resistance arteries of spontaneously hypertensive rats. J Hyper-tens 2000;18:885-91.
DOI
ScienceOn
|
| 7 |
Antonios TF, Rattary FM, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Rarefaction of skin capillaries in normotensive offspring of individuals with essential hypertension. Heart 2003;89:175-8.
DOI
|
| 8 |
Kim HZ, Jung K, Kim HM, Cheng Y, Koh GY. A designed angiopoietin-2 variant, pentameric COMP-Ang2, strongly activates Tie2 recep-tor and stimulates angiogenesis. Biochim Biophys Acta 2009:1793:772-80.
DOI
ScienceOn
|
| 9 |
Brindle NP, Saharinen P, Alitalo K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 2006;98:1014-23.
DOI
ScienceOn
|
| 10 |
Thurston G, Suri C, Smith K, et al. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999;286:2511-4.
DOI
|
webmaster
